EUVIMEDEUVIMED entdecken
Open Access

Proteomic signatures of adipocyte recruitment in breast cancer

Dimitrios G Argyris, Ioanna Ploumaki, Theodora Argyri, Dimitra P Anastasiadou, Nikos S Karagiannis, Maria P Pavlou, Evanthia T Roussos Torres, Outhiriaradjou Benard, Rachel B Hazan, Panagiota S Filippou, George S Karagiannis iD

Endocrine-Related Cancer · 01.05.2026 · 33 (5)

DOI: 10.1530/erc-25-0361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 09.04.2026. Verfasst von Dimitrios G Argyris und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Adipocytes, Breast Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) is increasingly recognized as a dynamic regulator of breast cancer progression, with adipocytes functioning as active contributors rather than passive bystanders. Here, we investigated the proteomic and morphologic reprogramming of breast cancer-associated adipocytes (BrCAAs) in response to triple-negative breast cancer (TNBC). Using conditioned medium from HCC1143 cells, we established an in vitro BrCAA model and performed mass spectrometry-based proteomics. Comparative profiling revealed 256 differentially expressed proteins, enriched for pathways including fatty acid degradation, carbon metabolism, and glycogen turnover, consistent with a metabolic shift from energy storage to energy supply. Gene ontology and protein–protein interaction analyses further identified cytoskeletal remodeling, adhesion dynamics, and secretory pathway activation, supporting BrCAA-driven microenvironmental remodeling. In the MMTV-PyMT mouse model, morphometric analysis demonstrated progressive size reduction and increased contour irregularity of adipocytes adjacent to tumors, correlating with proteomic evidence of metabolic stress. Importantly, BrCAAs localized at tumor interfaces were associated with increased microvessel density and CD105+ endothelial activation compared to desmoplastic zones. Proteomic enrichment highlighted pro-angiogenic remodeling, with validation of basigin (BSG), integrin αV (ITGAV), and 2,4-dienoyl-CoA reductase 1 (DECR1). Collectively, our findings establish BrCAAs as metabolically and structurally reprogrammed stromal components that promote tumor metabolism and localized angiogenesis, representing potential therapeutic targets in aggressive breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdipocytesBreast NeoplasmsTriple Negative Breast NeoplasmsFemaleAnimalsHumansProteomicsMiceTumor MicroenvironmentCell Line, TumorMetabolic Reprogramming

Stichwörter der Autor:innen

angiogenesisbreast cancercancer-associated adipocytesmetabolic reprogrammingproteomicstumor microenvironment

Autor:innen und Institutionen

  • Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Tumor Microenvironment & Metastasis Program, Montefiore-Einstein Comprehensive Cancer Center, Bronx, New York, USA.
  • 4th Department of Internal Medicine, Medical School, University General Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
  • School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Gruss Magnetic Resonance Research Center, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: George S Karagiannis

Förderung

  • NCI NIH HHS
  • NIH HHS

Zitieren

APA

Argyris, D. G., Ploumaki, I., Argyri, T., Anastasiadou, D. P., Karagiannis, N. S., Pavlou, M. P., Roussos Torres, E. T., Benard, O., Hazan, R. B., Filippou, P. S., & Karagiannis, G. S. (2026). Proteomic signatures of adipocyte recruitment in breast cancer. Endocrine-Related Cancer, 33(5). https://doi.org/10.1530/erc-25-0361

Vancouver

Argyris DG, Ploumaki I, Argyri T, Anastasiadou DP, Karagiannis NS, Pavlou MP, et al. Proteomic signatures of adipocyte recruitment in breast cancer. Endocrine-Related Cancer. 2026;33(5). doi:10.1530/erc-25-0361

BibTeX
@article{Argyris2026,
  author = {Argyris, Dimitrios G and Ploumaki, Ioanna and Argyri, Theodora and Anastasiadou, Dimitra P and Karagiannis, Nikos S and Pavlou, Maria P and Roussos Torres, Evanthia T and Benard, Outhiriaradjou and Hazan, Rachel B and Filippou, Panagiota S and Karagiannis, George S},
  title = {Proteomic signatures of adipocyte recruitment in breast cancer},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1530/erc-25-0361}
}
Kostenlos starten →